Effects of mitotane treatment on human steroid metabolism: implications for patient management

Mitotane (o,p'-DDD), an oral adrenolytic agent for treatment of advanced adrenocortical carcinoma (ACC), is reported to inhibit cortisol biosynthesis in vitro and enhance production from exogenous cortisol of urinary 6β-hydroxycortisol and unidentified polar unconjugated metabolites. We examine...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghataore, L, Chakraborti, I, Aylwin, S J, Schulte, K-M, Dworakowska, D, Coskeran, P, Taylor, N F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioScientifica 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3682235/
https://www.ncbi.nlm.nih.gov/pubmed/23781302
http://dx.doi.org/10.1530/EC-12-0028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3682235/
https://www.ncbi.nlm.nih.gov/pubmed/23781302
http://dx.doi.org/10.1530/EC-12-0028

Ejemplares similares